Answers are grounded in this paper and cite their sources.
This Viewpoint discusses a recent FDA-commissioned joint clinical practice guideline to help clinicians decide when and how to reduce or discontinue benzodiazepine prescriptions in a way that supports patient safety and optimal outcomes.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: